Sana Biotechnology, Inc. Other Nonoperating Income (Expense)
Sana Biotechnology, Inc. (SANA) reported Other Nonoperating Income (Expense) of $656.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-10
- Sana Biotechnology, Inc. other nonoperating income (expense) for the quarter ending 2026-06-30 was $656.00K, a 9.70% increase year-over-year.
- Sana Biotechnology, Inc. other nonoperating income (expense) for the quarter ending 2026-03-31 was $453.00K, a 81.93% increase year-over-year.
- Sana Biotechnology, Inc. other nonoperating income (expense) for the quarter ending 2025-12-31 was $1.10M, a 678.72% increase year-over-year.
- Sana Biotechnology, Inc. other nonoperating income (expense) for the quarter ending 2025-09-30 was $360.00K.
- Sana Biotechnology, Inc. other nonoperating income (expense) for fiscal 2025 was $2.31M.
- Sana Biotechnology, Inc. other nonoperating income (expense) for fiscal 2024 was -$4.51M.
- Sana Biotechnology, Inc. other nonoperating income (expense) for fiscal 2023 was -$52.00K.
- Sana Biotechnology, Inc. other nonoperating income (expense) for fiscal 2022 was -$674.00K, a 320.98% decline from fiscal 2021.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $656.00K 10-Q · filed 2026-08-10 | $1.11M 10-Q · filed 2026-08-10 | $2.21M derived: sum of 3 quarters · filed 2026-08-10 | $2.57M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $453.00K 10-Q · filed 2026-05-11 | $1.55M derived: sum of 2 quarters · filed 2026-05-11 | $1.91M derived: sum of 3 quarters · filed 2026-05-11 | $2.51M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $1.46M derived: sum of 2 quarters · filed 2026-03-03 | $2.06M derived: sum of 3 quarters · filed 2026-08-10 | $2.31M 10-K · filed 2026-03-03 |
| 2025-09-30 | $360.00K 10-Q · filed 2025-11-06 | $958.00K derived: sum of 2 quarters · filed 2026-08-10 | $1.21M 10-Q · filed 2025-11-06 | $1.35M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $598.00K 10-Q · filed 2026-08-10 | $847.00K 10-Q · filed 2026-08-10 | $988.00K derived: sum of 3 quarters · filed 2026-08-10 | $246.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $249.00K 10-Q · filed 2026-05-11 | $390.00K derived: sum of 2 quarters · filed 2026-05-11 | -$352.00K derived: sum of 3 quarters · filed 2026-05-11 | -$4.47M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $141.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$601.00K derived: sum of 2 quarters · filed 2026-03-03 | -$4.72M derived: sum of 3 quarters · filed 2026-03-03 | -$4.51M 10-K · filed 2026-03-03 |
| 2024-09-30 | -$742.00K 10-Q · filed 2025-11-06 | -$4.86M derived: sum of 2 quarters · filed 2025-11-06 | -$4.65M 10-Q · filed 2025-11-06 | -$4.87M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-06-30 | -$4.12M 10-Q · filed 2025-08-11 | -$3.91M 10-Q · filed 2025-08-11 | -$4.13M derived: sum of 3 quarters · filed 2026-03-03 | -$3.83M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-03-31 | $215.00K 10-Q · filed 2025-05-08 | -$9.00K derived: sum of 2 quarters · filed 2026-03-03 | $294.00K derived: sum of 3 quarters · filed 2026-03-03 | $210.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2023-12-31 | -$224.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $79.00K derived: sum of 2 quarters · filed 2026-03-03 | -$5.00K derived: sum of 3 quarters · filed 2026-03-03 | -$52.00K 10-K · filed 2026-03-03 |
| 2023-09-30 | $303.00K 10-Q · filed 2024-11-08 | $219.00K derived: sum of 2 quarters · filed 2024-11-08 | $172.00K 10-Q · filed 2024-11-08 | -$96.00K derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | -$84.00K 10-Q · filed 2024-08-08 | -$131.00K 10-Q · filed 2024-08-08 | -$399.00K derived: sum of 3 quarters · filed 2025-03-17 | -$505.00K derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | -$47.00K 10-Q · filed 2024-05-08 | -$315.00K derived: sum of 2 quarters · filed 2025-03-17 | -$421.00K derived: sum of 3 quarters · filed 2025-03-17 | -$619.00K derived: sum of 4 quarters · filed 2025-03-17 |
| 2022-12-31 | -$268.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | -$374.00K derived: sum of 2 quarters · filed 2025-03-17 | -$572.00K derived: sum of 3 quarters · filed 2025-03-17 | -$674.00K 10-K · filed 2025-03-17 |
| 2022-09-30 | -$106.00K 10-Q · filed 2023-11-08 | -$304.00K derived: sum of 2 quarters · filed 2023-11-08 | -$406.00K 10-Q · filed 2023-11-08 | -$125.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$198.00K 10-Q · filed 2023-08-03 | -$300.00K 10-Q · filed 2023-08-03 | -$19.00K derived: sum of 3 quarters · filed 2024-02-29 | -$9.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$102.00K 10-Q · filed 2023-05-08 | $179.00K derived: sum of 2 quarters · filed 2024-02-29 | $189.00K derived: sum of 3 quarters · filed 2024-02-29 | $190.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $281.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $291.00K derived: sum of 2 quarters · filed 2024-02-29 | $292.00K derived: sum of 3 quarters · filed 2024-02-29 | $305.00K 10-K · filed 2024-02-29 |
| 2021-09-30 | $10.00K 10-Q · filed 2022-11-02 | $11.00K derived: sum of 2 quarters · filed 2022-11-02 | $24.00K 10-Q · filed 2022-11-02 | $53.00K derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-06-30 | $1.00K 10-Q · filed 2022-08-04 | $14.00K 10-Q · filed 2022-08-04 | $43.00K derived: sum of 3 quarters · filed 2023-03-16 | $87.00K derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-03-31 | $13.00K 10-Q · filed 2022-05-10 | $42.00K derived: sum of 2 quarters · filed 2023-03-16 | $86.00K derived: sum of 3 quarters · filed 2023-03-16 | $105.00K derived: sum of 4 quarters · filed 2023-03-16 |
| 2020-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $73.00K derived: sum of 2 quarters · filed 2023-03-16 | $92.00K derived: sum of 3 quarters · filed 2023-03-16 | $97.00K 10-K · filed 2023-03-16 |
| 2020-09-30 | $44.00K 10-Q · filed 2021-11-08 | $63.00K derived: sum of 2 quarters · filed 2021-11-08 | $68.00K 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $19.00K 10-Q · filed 2021-08-04 | $24.00K 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | $5.00K 10-Q · filed 2021-05-05 | |||
| 2019-12-31 | -$29.00K 10-K · filed 2022-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |